Recursion Pharmaceuticals IPO

Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.

Register for Details

For more details on financing and valuation for Recursion Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Recursion Pharmaceuticals's ticker symbol?


What is Recursion Pharmaceuticals's stock price?

7.92 as of 9/22/23

Learn more about Recursion Pharmaceuticals

Forge green plus iconForge green minus icon

What is Recursion Pharmaceuticals funding to date?

Recursion Pharmaceuticals has raised $333.7MM to date.
Forge green plus iconForge green minus icon

When was Recursion Pharmaceuticals founded?

Recursion Pharmaceuticals was founded in 2013.
Updated on: Jun 12, 2022